17, 4Ј-H), 5.81 (1 H, ddd, J 6, 10 and 17, 3Ј-H), 7.02–7.09 (2 H,
m, ArH), 7.27 (1 H, t, J 8, ArH) and 7.36 (1 H, d, J 8, ArH); of
minor isomer 1.70–1.80 (1 H, m, 1Ј-H), 2.06–2.15 (1 H, m, 1Ј-
H), 2.67 (1 H, br s, OH), 3.44 (3 H, s, NMe), 3.67 (1 H, dd, J 7
and 8, 2-H), 4.32 (1 H, br s, 2Ј-H), 5.09 (1 H, d, Jcis 9, 4Ј-H), 5.25
(1 H, d, Jtrans 17, 4Ј-H), 5.76–5.84 (1 H, m, 3Ј-H), 6.97–7.08 (2
H, m, ArH), 7.25 (1 H, t, J 7, ArH) and 7.52 (1 H, d, J 7, ArH);
δC(CDCl3) of major isomer 32.6 (q), 36.7 (t), 39.4 (d), 70.3 (d),
115.6 (t), 117.4 (d), 122.2 (s), 123.6 (d), 127.2 (d), 128.6 (d),
139.5 (s) and 168.0 (s); of minor isomer 32.6 (q), 36.4 (t), 40.3
(d), 70.0 (d), 114.9 (t), 117.4 (d), 123.4 (d), 123.5 (d), 127.2 (d),
128.6 (d), 140.2 (s) and 168.2 (s); m/z 249 (M+, 100%). [3-(3-
Chlorobenzoyloxy)-2-hydroxy-4-phenylselenobutyl]-4-methyl-
2H-benzothiazin-3(4H)-one 20 was isolated as a mixture of
diastereoisomers composing the first (129 mg, 49%) and the
second (74 mg, 28%) fractions, respectively; the first fraction
was a yellow oil (Found: 561.0266. C26H24ClNO4SSe requires
561.0280); νmax(NaCl)/cmϪ1 3450 (OH), 1730 (C=O) and 1665
(C=O); δH (CDCl3) 2.11–2.16 (1 H, m, 1Ј-H), 2.18 (1 H, br s,
OH), 2.32–2.39 (1 H, m, 1Ј-H), 3.39 (3 H, s, NMe), 3.61 (1 H, br
m, 3Ј-H), 3.71 (1 H, dd, J 5 and 9, 2-H), 4.15 (1 H, br m, 2Ј-H),
4.60 (1 H, dd, J 5 and 11, 4Ј-H), 4.70 (1 H, d, J 9 and 11, 4Ј-H),
7.01–7.03 (2 H, m, ArH), 7.23 (4 H, br m, ArH), 7.30–7.36 (2 H,
m, ArH), 7.50 (1 H, d, J 7, ArH), 7.52–7.57 (2 H, m, ArH), 7.82
(1 H, d, J 8, ArH), and 7.91 (1 H, s, ArH); δC(CDCl3) 32.4 (q),
36.1 (t), 40.0 (d), 51.1 (d), 65.6 (t), 68.2 (d), 117.3 (d), 121.9 (s),
123.6 (d), 127.2 (d), 127.7 (d), 128.4 (s), 128.6 (d), 129.2 (d),
129.5 (d), 129.6 (d), 131.5 (s), 133.0 (d), 134.2 (d), 134.4 (s),
139.3 (s), 165.0 (s) and 167.5 (s); m/z 561 (M+, 3%) and 139
(100); the second fraction was also a yellow oil (Found:
561.0273. C26H24ClNO4SSe requires 561.0279); νmax(NaCl)/
cmϪ1 3430 (OH), 1720 (C=O) and 1660 (C=O); δH (CDCl3) 1.85
(1 H, ddd, J 7, 8 and 12, 1Ј-H), 1.94 (1 H, br s, OH), 2.57 (1 H,
ddd, J 7, 10 and 12, 1Ј-H), 3.44 (3 H, s, NMe), 3.67 (1 H, t, J 7,
2-H), 3.79 (1 H, br m, 3Ј-H), 4.21 (1 H, br m, 2Ј-H), 4.61 (1 H,
dd, J 5 and 12, 4Ј-H), 4.71 (1 H, dd, J 9 and 12, 4Ј-H), 6.98 (1 H,
t, J 7, ArH), 7.06 (1 H, d, J 8, ArH), 7.23–7.28 (5 H, m, ArH),
7.36 (1 H, t, J 8, ArH), 7.52 (1 H, d, J 8, ArH), 7.57–7.59 (2 H,
m, ArH), 7.85 (1 H, d, J 7, ArH) and 7.93 (1 H, s, ArH);
δC(CDCl3) 32.9 (q), 35.5 (t), 41.2 (d), 51.9 (d), 65.9 (t), 68.5 (d),
117.7 (d), 122.1 (s), 123.9 (d), 127.6 (d), 128.1 (d), 128.7 (s),
128.8 (d), 129.5 (d), 129.9 (d), 130.0 (d), 131.8 (s), 133.4 (d),
134.6 (d), 134.8 (s), 139.8 (s), 165.4 (s) and 168.5 (s); m/z 561
(M+, 6%) and 139 (100).
X-Ray study of 2Ј-isopropenyl-2Ј,4-dimethyl-2H-benzothiazine-
2-spirocyclopropan-3(4H)-one 4a
A colourless prism was mounted on a glass fibre and trans-
ferred to the diffractometer.
Crystal data. C15H17NOS, M = 259.37. Monoclinic, a =
11.825(3), b = 9.659(3), c = 12.386(3) Å, β = 103.79(2)Њ, V =
1373.9(5) Å3 (from setting angles of 20 centred reflections
with 20.1 ≤ 2θ ≤ 26.4Њ, λ = 0.710 73 Å, T = 298 K), space group
P21/a (alt P21/c, No. 14), Z = 4, Dx = 1.254 cm3, colourless
prism 0.2 × 0.2 × 0.1 mm, µ(Mo-Kα) = 0.213 mmϪ1
.
Data collection and processing. Rigaku AFC-5R four-circle
diffractometer with 12 kW rotating anode generator, ω/2θ
scans with
ω scan width (1.52 + 0.30 tan θ)Њ, graphite-
monochromated Mo-Kα X-radiation; 3508 reflections meas-
ured to 2θmax = 55Њ, 3354 unique (merging R = 0.046), giving
1443 with F ≥ 6σ(F) which were retained in all calculations. No
crystal decay was observed and no corrections were applied for
absorption.
Structure solution and refinement. Automatic direct
methods12 (all non-H atoms). Full-matrix least-squares refine-
ment 13 with all non-H atoms anisotropic.
2
2
The weighting scheme w = 4Fo /σ2(Fo ) gave satisfactory
agreement analyses. Final R = 0.047, Rw = 0.051, S = 1.45 for
163 refined parameters. The final ∆F synthesis showed no peaks
above ± 0.20 e ÅϪ3
.
Detailed crystallographic results for this study have been
deposited with the Cambridge Crystallographic Data Centre.
Any requests for this material should be accompanied by a full
bibliographic citation together with the reference number
CCDC 207/64. For details of this scheme, see Instructions for
Authors (1997), J. Chem. Soc., Perkin Trans. 1, 1997, Issue 1.
Acknowledgements
We are grateful to Dr Kenji Kano for the electroreduction
studies. This work was supported in part by a grant from the
Ministry of Education, Science and Culture.
References
1 M. Fujita, S. Ito, A. Ota, N. Kato, K. Yamamoto, Y. Kawashima,
H. Yamauchi and J. Iwao, J. Med. Chem., 1990, 33, 1898; A. Ota,
H. Suhara and Y. Kawashima, Chem. Pharm. Bull., 1992, 40, 833.
2 T. Aotsuka, H. Hosono, T. Kurihara, Y. Nakamura, T. Matsui and
F. Kobayashi, Chem. Pharm. Bull., 1994, 42, 1264.
3 T. Kataoka, K. Tsutsumi, T. Iwama, H. Shimizu and M. Hori,
Tetrahedron Lett., 1990, 31, 3027; T. Kataoka, T. Iwama, K. Tsut-
sumi, Y. Nakamura, H. Matsumoto, H. Shimizu and M. Hori,
J. Chem. Res., 1992 (S), 393; (M), 3153.
4 E. J. Corey and S. W. Walinsky, J. Am. Chem. Soc., 1972, 94, 8932;
H. Ishibashi, Y. Kitano, H. Nakatani, M. Okada, M. Ikeda,
M. Okura and Y. Tamura, Tetrahedron Lett., 1984, 25, 423; H. Ishi-
bashi, Y. Kitano, H. Nakatani, M. Ikeda and Y. Tamura, J. Chem.
Soc., Perkin Trans. 1, 1986, 1763.
Thermal rearrangement of vinylcyclopropane derivatives 4
General procedure. A solution of vinylcyclopropane 4 (0.5
mmol) in benzene (5 cm3) was heated at 230 ЊC in a sealed tube
for 6 h. After cooling, the reaction mixture was evaporated and
the residue was purified by preparative TLC eluting with ethyl
acetate–hexane
(1:10)
to
give
3Ј,4,4Ј-trimethyl-2H-
benzothiazine-2-spirocyclopent-3Ј-en-3(4H)-one 21a as colour-
less prisms, mp 84.5–86.0 ЊC (Found: C, 69.2; H, 6.6; N, 5.4.
C15H17NOS requires C, 69.46; H, 6.61; N, 5.40%); νmax(KBr)/
cmϪ1 1660 (C=O); δH (CDCl3) 1.57 (6 H, s, Me × 2), 2.30 (2 H,
d, J 16, CH2), 3.11 (2 H, d, J 16, CH2), 3.46 (3 H, s, NMe), 6.99
(1 H, t, J 7, ArH), 7.04 (1 H, d, J 7, ArH), 7.20 (1 H, t, J 7, ArH)
and 7.30 (1 H, d, J 7, ArH); δC(CDCl3) 13.2 (q), 32.8 (q), 47.9
(t), 48.6 (s), 116.9 (d), 122.9 (d), 126.9 (d), 127.5 (s × 2), 128.8
(d), 140.2 (s) and 169.8 (s); m/z 259 (M+, 38%) and 121 (100).
4-Methyl-2H-benzothiazine-2-spirocyclopent-3Ј-en-3(4H)-
one 21b, colourless prisms, mp 47–49 ЊC (Found: C, 67.4; H,
5.6; N, 6.1. C13H13NOS requires C, 67.50; H, 5.67; N, 6.06%);
νmax(KBr)/cmϪ1 1670 (C=O); δH (CDCl3) 2.40 (2 H, d, J 16,
CH2), 3.15 (2 H, d, J 16, CH2), 3.47 (3 H, s, NMe), 5.61 (2 H, br
s, olefinic H), 7.00 (1 H, t, J 7, ArH), 7.06 (1 H, d, J 7, ArH),
7.25 (1 H, t, J 7, ArH) and 7.31 (1 H, d, J 7, ArH); δC(CDCl3)
32.9 (q), 42.8 (t), 50.7 (s), 117.0 (d), 122.6 (s), 123.0 (d), 127.0
(d), 127.2 (d), 128.9 (d), 140.2 (s) and 169.4 (s); m/z 231 (M+,
52%) and 139 (100).
5 H. Shimizu, S. Miyazaki, T. Kataoka and M. Hori, Tetrahedron
Lett., 1991, 32, 5571; H. Shimizu, S. Miyazaki, T. Kataoka and
M. Hori, J. Chem. Soc., Chem. Commun., 1992, 1586; H. Shimizu,
S. Miyazaki, T. Kataoka and M. Hori, J. Chem. Soc., Perkin Trans.
1, 1995, 1583.
6 T. Kataoka, Y. Nakamura, H. Matsumoto, T. Iwama and H. Shimi-
zu, Heterocycles, 1994, 38, 1733.
7 H. Tawada, Y. Sugiyama, H. Ikeda, Y. Yamamoto and K. Meguro,
Chem. Pharm. Bull., 1990, 38, 1238.
8 M. Hori, T. Kataoka, H. Shimizu and K. Tsutsumi, Tetrahedron
Lett., 1989, 30, 981; T. Kataoka, K. Tsutsumi, K. Kano, K. Mori,
M. Miyake, M. Yokota, H. Shimizu and M. Hori, J. Chem. Soc.,
Perkin Trans. 1, 1990, 3017.
9 T. Kataoka, T. Iwama, H. Shimizu and M. Hori, Phosphorus Sulfur
Silicon Relat. Elem., 1992, 67, 169.
10 T. Hudlicky, T. M. Kutchan and S. M. Naqvi, Org. React. (N.Y.),
1985, 33, 247; T. Hudlicky and J. W. Reed, in Comprehensive Organic
Synthesis, ed. B. M. Trost and I. Fleming, Pergamon Press, Oxford,
1991, vol. 5, p. 899.
11 P. Girard, J. L. Namy and H. B. Kagan, J. Am. Chem. Soc., 1980,
102, 2693.
J. Chem. Soc., Perkin Trans. 1, 1997
315